← Older posts

Research is a very strange thing.  The topics selected by researchers do not seem to have any direction.  They are selected at the whim of the researcher who decides what question needs to be addressed.  Consequently, it is sometimes difficult … Continue reading

For many years, conditions were treated and doctors did not really know whether they were achieving anything. Doctors tried to achieve good glycaemic control in people with diabetes without really knowing whether anything was being achieved. It was not until … Continue reading

The National Review of Asthma Deaths was the first fully comprehensive review of deaths from asthma across the UK. Led by the Royal College of Physicians (RCP), and conducted between February 2012 – 2013, the final report has recently been … Continue reading

Every so often we hear of new hope for the cure of diabetes.  Islet cell transplants were probably the first to be successfully used in a few patients.  However, much of the interest surrounds the use of stem cells. Stem … Continue reading

“An MP’s Committee has warned that drugs companies routinely withhold results of clinical trials from doctors, leaving them poorly informed about how to treat patients” This report from the Public Accounts Committee arose as a result of the Department of … Continue reading

If ever there was a “wonder drug”, then a statin would have a good chance of being called by such a name.  New guidance from America suggests that even more people would benefit from taking a statin than ever before. … Continue reading

Doctors have known for years that soluble (effervescent) preparations of drugs such as paracetamol contain quite high levels of salt.  They assumed, wrongly as it turns out, that patients did not take enough of the drugs to cause a problem. … Continue reading

The recent impact of the long trial on the benefits of HRT has again rasied the whole  question of clinical trials. The report: “Schierbeck LL, Rejnmark L, Tofteng CL et al, Effect of hormone replacement therapy on cardiovascular events in … Continue reading

After months of often tedious discussion, the use of HbA1C as a diagnostic tool has taken a final step towards universal acceptance with the publishing of the findings of an “expert consensus group” on whether we, in the UK should … Continue reading

Once again, the thorny issue of drug licensing has arisen.  The two sides to the question have been drawn up in lines of battle for years. “On your left – Mum denied new cancer cure drug” “On your right – … Continue reading

← Older posts
Page 1 of 212